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Risk factors for lymphatic filariasis
in two villages of the Democratic Republic
of the Congo
Cédric B. Chesnais1*, Naomi‑Pitchouna Awaca‑Uvon2, Johnny Vlaminck3, Jean‑Paul Tambwe2, Gary J. Weil4,
Sébastien D. Pion1 and Michel Boussinesq1

Abstract
Background: Little is known regarding risk factors for lymphatic filariasis (LF) in Central Africa. To expand on what is
known, we studied the epidemiology of LF in two endemic villages in the Democratic Republic of the Congo.
Methods: Dependent variables were Wuchereria bancrofti antigenaemia detected with filarial test strips (FTS) and
microfilaraemia detected by night blood smears. The following factors were investigated: sex, age, the use of bednets,
the use of latrines, hunting, fishing and agricultural activities, history of treatment with anthelmintic drugs, overnight
stays in the bush, population density, the number of household members, and distance to rivers. Mixed multivariate
logistic regression models were used.
Results: Two hundred and fifty nine out of 820 (31.6%) of subjects aged ≥ 5 years had W. bancrofti antigenaemia and
11.8% (97/820) had microfilaraemia. Multivariable analysis of risk factors for antigenaemia demonstrated increased risk
for males (aOR = 1.75, 95% CI: 1.20–2.53, P = 0.003), for older individuals (aOR = 9.12 in those aged > 35 years, 95% CI:
4.47–18.61, P < 0.001), for people not using bednets (aOR = 1.57, 95% CI: 1.06–2.33, P = 0.023), for farmers (aOR = 2.21,
95% CI: 1.25–3.90, P = 0.006), and for those who live close to a river (aOR = 2.78, 95% CI: 1.14–6.74, P = 0.024). Signifi‑
cant risk factors for microfilaraemia included age, male gender, overnight stay in the bush, and residence close to a
river (aOR = 1.86, 2.01, 2.73; P = 0.011, 0.010, 0.041; for the three latter variables, respectively). People who reported
having taken levamisole (n = 117) during the prior year had a significantly decreased risk of having filarial antigenae‑
mia (aOR = 0.40, 95% CI: 0.21–0.76, P = 0.005).
Conclusions: Age, sex, not using bednets, and occupation-dependent exposure to mosquitoes were important risk
factors for infection with W. bancrofti in this study. The association with levamisole use suggests that the drug may
have prevented filarial infections. Other results suggest that transmission often occurs outside of the village. This
study provides interesting clues regarding the epidemiology of LF in Central Africa.
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Background
Lymphatic filariasis (LF), a major neglected tropical disease (NTD), is a mosquito-borne parasitic infection
caused by Wuchereria bancrofti, Brugia malayi and B.
timori. The Global Programme to Eliminate Lymphatic
Filariasis (GPELF) was launched in 2000 with the goal
of eliminating LF as a public health problem by 2020. To
date, more than 7 billion treatments have been distributed during annual mass drug administration (MDA)
campaigns [1]. MDA is no longer required in 21 of 72
endemic countries, and 11 of these have been validated
by the World Health Organization (WHO) as having
eliminated LF as a public health problem [1].
LF elimination programmes are not as advanced in
Central Africa as in other regions, although there have
been improvements in MDA coverage in recent years.
Initially, the delay observed in Central Africa was due to
(i) a lack of accurate epidemiological and geographical
information on LF distribution [2–5]; (ii) concern about
the potential risk of serious adverse events after ivermectin treatment in areas where Loa loa is co-endemic [6];
and (iii) insecurity and political instability in some countries. In addition, large-scale mapping surveys conducted
in recent years revealed that LF distribution in this region
is highly focal [5] and that the total population requiring
MDA for LF was lower than expected [7]. Furthermore,
the circulating filarial antigen (CFA) detection test used
to map LF sometimes produces false positive results in
individuals with high Loa loa microfilarial densities [8].
Thus, mapping for LF based on CFA testing overestimated the extent of LF in some areas (e.g. in Cameroon)
[9].
In a previous paper, we investigated risk factors associated with W. bancrofti infection in a village in the Republic of Congo where baseline infection level was moderate
(CFA prevalence: 17%) [5]. That study showed that overnight stays in the bush for hunting or fishing activity was
a significant risk factor for filarial infection. The present
study was conducted to assess risk factors in villages
located in the western part of the Democratic Republic of
the Congo (DRC) where LF prevalence was much higher
than in the Republic of Congo study. This additional
study is important, because it adds significant new information on individual risk factors for LF in Central Africa.
Methods
Context of the study

This study was carried out with baseline data collected
in June 2014 during a community-based study to assess
the impact of biannual mass administration of albendazole on LF [10]. In July 2013, community surveys were
performed in 13 villages of the Kwilu Province. The survey area was delineated by Bandundu-ville in the west,
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Beno in the east, and the Kasaï and Kwilu rivers in the
north, until 20 km south. Filarial antigenaemia rates were
strongly heterogeneous, and Mbumkimi and Misay were
the only villages where the prevalence of antigenaemia
reached 40%.
Study site

The study was conducted in two villages, Mbumkimi and
Misay (3°31′41″S, 17°37′44″E and 3°30′44″S, 17°37′29″E,
respectively) in the Bagata territory of Kwilu Province,
about 50 km east of the capital city of the province,
Bandundu-ville. The villages are located less than 2 km
apart, and both are located on the northern bank of the
Kwilu River. The river is approximately 200 m wide near
the study villages. In addition, a stream several meters
wide, called Nsitim, flows into the Kwilu River approximately 300 m east of Mbumkimi (Fig. 1). The vegetation
is comprised of forest savanna with gallery forests along
the rivers. There are two seasons: a dry season from May
to October, and a rainy season from November to April.
The populations of Mbumkimi and Misay, as assessed
by a census conducted in May 2014, were 843 and 423,
respectively. The main occupational activities in the study
villages are agriculture and fishing.
Survey methods

In June-July 2014, adults and children ≥ 5 years of age
were invited to participate in the community survey. Participants who signed a written consent form (assent plus
written consent from at least one parent was required for
children < 18 years of age) were screened for CFA using
the Alere Filariasis Test Strip (FTS, Scarborough, ME,
USA) [11]. Capillary blood was collected by finger prick
using a sterile disposable lancet in a hematocrit tube. The
blood (70 μl) was then transferred on the sample application pad of the strip following the manufacturer’s instructions. A single trained person read all of the tests at
10 min, and results were recorded as negative or positive.
Participants with a positive FTS result were re-sampled
between 10:00 PM and midnight to prepare two thick
blood smears (70 µl) for detection of microfilariae (mf ).
Slides were dehaemoglobinized, stained with Giemsa
within 24 h, and read by two independent microscopists. The arithmetic mean count from the two slides was
recorded as mf density (expressed in mf/70 μl). All individuals with a negative FTS result were considered to be
amicrofilaraemic.
Questionnaire

A standardized questionnaire was used to collect demographic information (full name, age, sex), information
on the peridomestic environment, and the individual’s
activities outside the immediate village environment.
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Fig. 1 Study area of Misay and Mbumkimi. Each point indicates the location of a household. The red star indicates the location of the villages

Questions on the peridomestic environment asked about
access to latrines (yes/no) and use of bednets during
the previous night (yes/no) as a proxy for regular usage
of bednets. Other questions included: hunting (yes/no),
fishing (yes/no), agricultural activities (in three categories: none; yes, in fields located on the same side of the
Kwilu River; and yes, in fields located across the Kwilu
River). Participants were also asked if they occasionally
stayed overnight in the bush (no/yes). Participants were
also asked whether they had taken anthelmintic drugs
within the previous year (yes/no); if the answer was yes,
the name of the drug was recorded.
Environmental assessment

Houses were georeferenced using GPS on smartphones.
Geospatial data were collected in World Geodetic System (WGS) 1984 geographical coordinates and projected
using the WGS 1984 World Mercator coordinate reference system. The accuracy of georeferencing was 4 m.
Roads and rivers were also mapped.

Statistical analysis
Dependent variables

Analyses were conducted using CFA and microfilaraemia
(mf ) as dependent variables.
Explanatory variables

The following individual factors were coded as categorical variables: village of residence (Mbumkimi or Misay),
sex (M/F), use of latrines (yes/no), use of bednet (yes/no),
hunting (yes/no), fishing (yes/no), occasional overnight
stays in the bush (yes/no), agricultural activities (no; yes,
in fields located on the same side; yes, in fields located
across the Kwilu River), and history of anthelmintic
treatment (yes/no). Age was categorized into 4 balanced
classes: 5–10; 11–20; 21–40; and > 40 years. The number
of members for each household was included as a quantitative variable. Regarding the environmental variables,
distances (as the crow flies) between each house and each
river (Kwilu and Nsitim rivers) were calculated categorized using ArcGIS v.10.4 (ESRI, Redlands, CA, USA) as
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Abbreviations: n, number of subjects; FTS-positive, individuals with positive filarial test strip result; mf-positive, individuals with microfilaraemia; mf, microfilarial; GM, geometric mean microfilaraemia in microfilaremic
individuals
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Table 1 Wuchereria bancrofti prevalence and intensity of infection in Misay and Mbumkimi
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follows: 0–300; 300–400; and > 400 m. The GPS location
was unavailable for 24 households, corresponding to 60
individuals (7.3% of the study population), and these were
considered to be missing data. Lastly, we defined the
population density (in the confines around the outermost
houses) using ArcGIS (inhabitants per k m2), and then,
each residence was categorized into three balanced levels
(low, intermediate, and high population density).
Risk factors associated with filarial infection

Bivariate analyses were conducted using Chi-square tests
to evaluate differences between FTS positive and negative individuals and between individuals with and without microfilaraemia. A multivariable analysis including
all variables associated with CFA or mf at P < 0.25 by
bivariate analysis was performed using a descending procedure. We used mixed multivariable logistic regression
models with household as random effect on the intercept. From the final models, we estimated the population
attributable fractions (PAF) for each independent variable by the presence of CFA and mf (i.e. we estimated the
proportional reduction in the prevalence of CFA and mf
if the risk factor was absent). This was performed using
the punaf package in STATA software. All analyses were
performed using the STATA v.12.1 software (StatCorps,
LP, College Station, TX, USA).

Results
Study population

A total of 1290 people, including 1033 aged ≥ 5 years,
were recorded in the two villages during the census.
About 100 individuals could not be registered (e.g. due to
refusal), and thus the total population in the two villages
was about 1400. Of the 1290 people recorded, 820 subjects [including 383 males (46.7%) living in 255 households] were tested for filarial antigenaemia by FTS. Their
median age was 20 years (range: 5–79 years, interquartile
range: 10–35 years). Parasitological results are shown in
Table 1 and univariate analyses of risk factors for W. bancrofti infection are shown in Table 2. Among participants
who reported having taken anthelmintic drugs during the
past year (n = 223), 117 had taken levamisole, 53 mebendazole, 52 albendazole, and 1 pyrantel.
Filarial antigenaemia

The proportion of subjects with CFA in the study population was 31.6% (259/820). The prevalence was slightly
higher in males than in females (34.2 vs 29.3%, respectively; Pearson’s Chi-square test: χ2 = 2.28, df = 1,
P = 0.131) and increased linearly with age for both sexes
leveling off at 40–50 years of age (Fig. 2).
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Microfilaraemia

Microfilaria were detected in night blood from 37%
(97/259) of participants with positive FTS results. The
W. bancrofti mf prevalence was 11.8% (97/820), with a
higher value in males than in females (14.4 vs 9.6%; Pearson’s Chi-square test: χ2 = 4.41, df = 1, P = 0.036). Microfilaraemia prevalence increased linearly with age between
5 and 50 years in males, while a sharp increase in mf
prevalence was observed in females after age 40 (Fig. 3).
Risk factors for filarial antigenaemia

In the final model (Table 3), the risk of filarial antigenaemia increased with age (adjusted odd ratio aOR = 9.12,
95% confidence interval CI: 4.47–18.61, P < 0.001, in
those aged > 35 years, when compared with individuals aged 5–10 years, P < 0.001). Males had a higher CFA
prevalence than females (aOR = 1.75, 95% CI: 1.20–2.53,
P = 0.003). People who (i) did not use bednets, (ii) performed agricultural activities, (iii) had not taken anthelmintics during the past year, and (iv) lived near the Nsitim
River (Fig. 4, kernel interpolation), had a significantly
increased risk for CFA (Table 3). Random household
effect, representing all unmeasured contextual effects
common within a household (e.g. habits, genetic component), was significant (likelihood-ratio Chi-bar-square
test: χ2 = 6.78, df = 13, P = 0.005). Lastly, the calculation
of the attributable parts of each variable (Table 4) indicates that agricultural activities were responsible for the
highest PAF value (30.5%, 95% CI: 7.4–47.9), and that the
total PAF related to activities outside of the villages (e.g.
agricultural activities plus staying overnight in the bush)
was 36.0%. Similarly, the total PAF due to factors internal
to the village (use of bednets plus proximity to the river)
was 18.9%. Interestingly, not having taken anthelmintics
was found to have an important impact (PAF = 25.7%,
95% CI: 8.9–39.4). When models were run to consider
the different drugs taken by the subject, only history of
levamisole treatment was significantly associated with a
decreased risk for CFA (aOR = 0.40, 95% CI: 0.21–0.76,
P = 0.005) (Table 5). Among those taking levamisole, no
drugs, mebendazole, and albendazole, 16.2, 34.8, 30.2,
and 30.8% were FTS positive, respectively (Pearson’s Chisquare test: χ2 = 15.64, df = 3, P = 0.002). Interestingly, a
history of levamisole treatment was more common in the
youngest age group (Pearson’s Chi-square test: χ2 = 50.84,
df = 9, P < 0.0001). There was no interaction between the
drug variable and age in an analysis that used anthelmintic drugs as a binary variable (likelihood-ratio Chi-square
test: χ2 = 5.71, df = 3, P = 0.769) or as a categorical variable by name of drug (likelihood-ratio Chi-square test:
χ2 = 1.24, df = 9, P = 0.743).
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Table 2 Univariate analysis of risk factors for Wuchereria bancrofti antigenaemia
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Fig. 2 Age-profiles for W. bancrofti antigenaemia prevalence. Males
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Risk factors for W. bancrofti microfilaraemia

In the final model, age was a strong risk factor for microfilaraemia (aOR = 12.68, 95% CI: 4.22–38.07, for persons
> 35 years of age) (Table 6). Male sex was linked to a
higher prevalence of mf (aOR = 1.86, 95% CI: 1.15–3.01,
P = 0.011). Persons who occasionally stayed overnight
in the bush (aOR = 2.01, 95% CI: 1.18–3.42, P = 0.010),
who had not taken anthelmintics (aOR = 2.50, 95% CI:
1.33–4.72, P = 0.005), and who lived near the Nsitim
River (aOR = 2.73, 95% CI: 1.04–7.11, P = 0.046) had
an increased risk for mf. Household effect was not significant (Likelihood-ratio Chi-bar-square test: χ2 = 0.41,
df = 10, P = 0.260). Lastly, the PAF related to previous
anthelmintic treatment suggested that if all people in the
study had taken levamisole within the past year, the mf
prevalence in the study villages might have been 43.3%
lower than what was observed (Table 4). As seen in the
CFA analyses, only levamisole was significantly associated with a decreased risk for mf (aOR = 0.41, 95% CI:
0.17–0.99, P = 0.048) (Table 5). However, when analyses
were restricted to the 259 FTS positive individuals, only
overnight stays in the bush tended to be associated with
mf (aOR = 1.69, 95% CI: 0.94–3.03, P = 0.078). Consequently, levamisole (or other anthelmintic treatment)
was not significantly associated with mf in individuals
infected with W. bancrofti.

Discussion
Little is known regarding the risk factors associated with
LF in Central Africa and its micro-epidemiology. Results
from this study confirm some findings from a similar
study that was conducted in the village of Seke Pembe,
in the Republic of Congo [5], namely that the risk of

infection with W. bancrofti increased with age, and males
had higher infection prevalences than females, independent of the other variables. These profiles are commonly
seen in other areas around the world. The use of bednets
was a protective factor against LF infection, and anthelmintic treatment during the past year appeared to be
strongly protective, especially regarding mf prevalence.
There was no difference in bednet use for individuals who
had or had not taken anthelmintics (Pearson’s Chi-square
test: χ2 = 0.0016, df = 1, P = 0.968), and there was no
interaction between these two variables (likelihood-ratio
Chi-square test: χ2 = 0.48, df = 1, P = 0.489); this suggests
that bednets and anthelmintic treatment had independent protective effects.
The protective effect of anthelmintics appeared to be
only significant for levamisole. Published studies of the
effects of levamisole for W. bancrofti and Brugia malayi
infections show that it temporarily reduces mf densities
(ranging from 78.8 to 98.5%) [12–16]. However, while
levamisole is known to have a transient microfilaricidal
effect, none of these trials suggested that it has a macrofilaricidal effect. Thus, the lower CFA prevalence in persons who reported levamisole use was unexpected. It is
possible that levamisole has previously unrecognized
macrofilaricidal or prophylactic effects on W. bancrofti.
This unexpected result should be investigated more thoroughly, because we cannot exclude possible confounding factors at this time, and because this study was not
specifically designed to assess the effect of anthelminthic
drugs on the acquisition of filarial infection. We cannot
exclude a possible similar protective effect of albendazole
since relatively few people reported having taken albendazole during the year prior to our survey.
Our study identified several activities as risk factors for
CFA and microfilaraemia. Infection was more frequent
in individuals who worked in agriculture. However, the
risk of infection was not higher in persons who worked
in fields located across the Kwilu River. This suggests that
frequent river crossings did not increase workers’ exposure to infective mosquitoes. This conclusion is consistent with the finding that proximity of households to the
Kwilu River was not significantly associated with a higher
risk of infection. The PAF of risk for infection associated
with agricultural activity was second only to anthelmintic
intake, the latter of which might be considered to be an
intervention rather than a risk factor. In addition, given
the link between agricultural activity and LF test positivity, it would be of interest to try to elucidate the causal
mechanism driving this relationship. These could identify
possibly beneficial interventions for the population.
It is interesting to note that results from this study,
which suggest a large amount of LF transmission
occurs outside of the village, are consistent with results
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of our prior study in Republic of Congo [5]. A history
of frequent fishing was not associated with the presence of infection, with or without adjusting for age,
sex or agricultural activity. This result may be because
most fishing activities occur during the day and not in

the evening when exposure to Anopheles mosquitoes is
highest.
The population density around houses and the number
of household members were not associated with infection risk. This result suggests that there was no dilution
or concentration effect on transmission related to the
domestic or peridomestic environment. This finding
also suggests that transmission does not mainly occur
in or near residences. Studies in east Africa reported
that Anopheles densities decrease significantly beyond
400 m from water sites [17, 18]. Similarly, a meta-analysis showed that increasing distance away from breeding
sites was associated with an 11% reduction in malaria
risk per 100 m [19]. We have limited information on the
mosquito fauna in the study area. Studies in and around
Bandundu-ville detected abundant A. gambiae (s.l.) [20],
especially complex member A. coluzzii (s.s.) [21]. However, A. funestus (s.l.), and to a lesser extent, A. moucheti
(s.l.) and A. nili (s.l.) might also be significant vectors for
LF in the study area [22].
It is interesting that proximity to the Nsitim River was
a risk factor while proximity to the Kwilu River was not.
The Kwilu is a large river (200 m wide), while the Nsitim
River is a small stream that flows slowly in a dense gallery

Table 3 Multivariable logistic regression analysis of risk factors for filarial antigenaemia in the total population. Likelihood-ratio test for
random effect vs fixed effect model, final model (P = 0.005)
Variable

Category

Full model

Final model

Adj OR (95% CI)

P

Adj OR (95% CI)

P

11–20

2.72 (1.42–5.20)

0.002

3.03 (1.59–5.75)

0.001

21–35

5.19 (2.53–10.65)

<0.001

5.46 (2.68–11.12)

0.001

> 35

8.23 (4.05–16.73)

<0.001

9.12 (4.47–18.61)

<0.001

Sex (ref: female)

Male

1.82 (1.25–2.66)

0.002

1.75 (1.20–2.53)

0.003

Village (ref: Mbumkimi)

Misay

0.92 (0.54–1.56)

0.758

Bednets (ref: yes)

No

1.46 (0.99–2.14)

0.056

1.57 (1.06–2.33)

0.023

Latrines (ref: no)

Yes

0.88 (0.54–1.43)

0.609

Fishing (ref: no)

Yes

1.27 (0.83–1.94)

0.277

Occasional stay in the bush (ref: no)

Yes

1.35 (0.86–2.11)

0.186

1.45 (0.92–2.28)

0.105

Agriculture activity (ref: no)

Yes, same side

2.10 (1.07–4.11)

0.031

2.15 (1.11–4.17)

0.024

Yes, other side

2.07 (1.15–3.71)

0.015

2.21 (1.25–3.90)

0.006

No

1.77 (1.13–2.77)

0.012

1.82 (1.16–2.87)

0.010

na

2.10 (0.89–4.96)

0.090

2.05 (0.84–4.94)

0.111

Intermediate

0.99 (0.57–1.71)

0.969

High

1.31 (0.77–2.25)

0.322

na

1.51 (0.59–3.87)

0.387

300–400 m

1.40 (0.84–2.34)

0.198

1.41 (0.89–2.21)

0.140

0–300 m

2.44 (0.99–6.01)

0.052

2.78 (1.14–6.74)

0.024

300–400 m

0.64 (0.32–1.30)

0.216

0–300 m

1.23 (0.64–2.36)

0.543

1.04 (0.93–1.18)

0.475

Age (ref: 5–10 years-old)

Previous AH treatment (ref: yes)
Population density (ref: low)

Distance to Nsitim River (ref: > 400 m)
Distance to Kwilu River (ref: > 400 m)
Number of household members

Abbreviations: Adj OR, adjusted odds ratio; AH, anthelmintic drug; CI, confidence interval; na, not available
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Table 4 Population attributable fractions associated with the significant independent variables for filarial antigenaemia and
microfilaraemia
Variable

Antigenaemia
Population attributable
fraction

Microfilaraemia
95% CI

Population attributable
fraction

P

95% CI

P

Males

12.7

3.7–20.9

0.006

21.7

3.6–36.4

0.021

No bednet

9.4

1.8–16.3

0.016

–

–

–

No previous AH treatment

25.7

8.9–39.4

0.004

43.3

12.0–63.5

0.011

Occasional stay in the bush

5.5

0.1–11.3

0.078

17.0

2.8–29.1

0.020

Agricultural activity

30.5

7.4–47.9

0.013

–

–

–

Distance to Nsitim < 400 m

9.4

0.8–17.3

0.034

20.7

2.7–35.3

0.027

Abbreviation: AH, anthelmintic drug; CI, confidence interval

Table 5 Multivariable logistic regression analysis of risk factors for filarial antigenaemia and microfilaraemia in the total population
Variable

Category

Antigenaemia modela
Full model

Microfilaraemia modela
Final model

b

Adj OR (95% CI)

P

Full model
c

Adj OR (95% CI)

P

Final model
b

Adj OR (95% CI)

P

Adj OR (95% CI)d P

Previous AH treatment Levamisole (n = 117)

0.41 (0.22–0.76)

0.005 0.40 (0.21–0.76)

0.005 0.40 (0.16–0.98)

0.046 0.41 (0.17–0.99)

0.048

Mebendazole (n = 53) 0.75 (0.35–1.61)

0.460 0.77 (0.35–1.69)

0.509 0.52 (0.17–1.52)

0.237 0.56 (0.19–1.64)

0.291

Albendazole (n = 52)

0.79 (0.37–1.65)

(ref: no)

LR test random effect
a

0.525 0.73 (0.34–1.55)

0.414 0.36 (0.10–1.29)

0.115 0.35 (0.10–1.24)

0.104

0.065

0.005

0.252

0.197

As only one individual had taken pyrantel, the models were performed on 819 individuals (the subject having taken pyrantel was considered as missing data)

b

Adjusted on age, sex, latrine, bednets, village, occasional overnight stay in the bush, agricultural activity, fishing, distance to the Nsitim and Kwilu rivers, population
density and number of household members

c

Adjusted on age, sex, occasional overnight stay in the bush, bednets, distance to the Nsitim and Kwilu rivers, and agricultural activity

d

Adjusted on age, sex, occasional overnight stay in the bush, and distance to the Nsitim River

Abbreviations: Adj OR, adjusted odds ratio; AH, anthelmintic drug; CI, confidence interval; LR, likelihood ratio

forest. The local population goes to this small river for
bathing, for washing clothes and for collecting drinking
water. The access to the Nsitim is swampy and no crops
are grown in this area. Thus, this environment may be
favorable for specific Anopheles species such as A. moucheti (s.l.) or A. nili (s.l.) that breed in slow-flowing rivers [23, 24]. Further entomological studies are needed to
identify LF vectors in Central Africa.
It was also interesting that staying overnight in the
bush was a risk factor for mf. It is likely that this activity increases exposure to mosquitoes. This risk factor
was also identified in our prior study in the Republic of Congo [5]. People who acquire filarial infections
in the bush may constitute an important reservoir for

secondary transmission inside the village. These results
from two studies in different countries suggest that sylvatic or peri-sylvatic exposure to mosquitoes is important for LF transmission in Central Africa [5]. More
work is needed to compare vector species and densities
in villages and forested bush areas in LF endemic areas
in this region.

Conclusions
This study has provided useful information on the epidemiology of LF in Central Africa. Age, sex, environment,
and individual behavior were important risk factors for
infection, and these findings were consistent with those
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Table 6 Multivariable logistic regression analysis of risk factors for microfilaraemia in the total population. Likelihood-ratio test for
random effect vs fixed effect model, final model (P = 0.260)
Variable

Category

Full model

Final model

Adj OR (95% CI)

P

Adj OR (95% CI)

P

11–20

4.07 (1.26–13.03)

0.018

5.02 (1.64–15.32)

0.005

21–35

5.87 (1.73–20.00)

0.005

7.78 (2.57–23.56)

0.001

> 35

9.37 (2.84–30.92)

0.001

12.68 (4.22–38.07)

0.001

Sex (ref: female)

Male

1.99 (1.19–3.33)

0.008

1.86 (1.15–3.01)

0.011

Village (ref: Mbumkimi)

Misay

1.25 (0.60–2.58)

0.554

Bednets (ref: yes)

No

0.94 (0.57–1.56)

0.816

Latrines (ref: no)

Yes

1.05 (0.54–2.07)

0.882

Fishing (ref: no)

Yes

1.00 (0.56–1.76)

0.993

Occasional stay in the bush (ref: no)

Yes

1.92 (1.11–3.35)

0.020

2.01 (1.18–3.42)

0.010

Agricultural practice (ref: no)

Yes, same side

1.65 (0.62–4.44)

0.312

Yes, other side

1.67 (0.72–3.87)

0.235

No

2.54 (1.33–4.84)

0.005

2.50 (1.33–4.72)

0.005

na

0.94 (0.19–4.63)

0.939

0.78 (0.16–3.82)

0.757

Intermediate

1.32 (0.65–2.69)

0.446

High

1.65 (0.82–3.34)

0.163

na

1.77 (0.48–6.55)

0.389

300–400 m

2.37 (1.20–4.68)

0.013

1.97 (1.17–3.33)

0.011

0–300 m

3.02 (1.02–8.89)

0.046

2.73 (1.04–7.11)

0.041

300–400 m

1.00 (0.40–2.54)

0.989

Age (ref: 5–10 years-old)

Previous AH treatment (ref: yes)
Population density (ref: low)

Distance to Nsitim River (ref: > 400 m)
Distance to Kwilu River (ref: > 400 m)

0–300 m
Number of household members

1.52 (0.65–3.54)

0.335

0.99 (0.85–1.15)

0.908

Abbreviations: Adj OR, adjusted odds ratio; AH, anthelmintic drug; CI, confidence interval; na, not available

recently reported from a study in the Republic of Congo.
Additional studies with strong entomology components
should be conducted to further define the epidemiology and explain the highly focal distribution of LF in this
important region.
Abbreviations
GPELF: Global Programme to Eliminate Lymphatic Filariasis; MDA: mass drug
administration; LF: lymphatic filariasis; IVM: ivermectin; ALB: albendazole;
NTD: neglected tropical disease; FTS: filariasis test strip; CFA: circulating filarial
antigens; mf: microfilariae; DOLF: Death to Onchocerciasis and Lymphatic
Filariasis.
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